TCI Wealth Advisors’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Other funds holding INO
TCI Wealth Advisors's INO Position: Q1 2023 in Review
TCI Wealth Advisors sold out of Inovio Pharmaceuticals (INO) in Q1 2023, closing a stake of 140 shares — an estimated $2.62K sold.
TCI Wealth Advisors first reported a position in INO in Q3 2014 and held it in 22 quarters. The position peaked at $17K in Q3 2018. 174 funds tracked by Wall St. Rank hold INO as of Q1 2023.
- TCI Wealth Advisors reported no remaining Inovio Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
- TCI Wealth Advisors sold 140 Inovio Pharmaceuticals shares in Q1 2023, an estimated $2.62K.
- TCI Wealth Advisors first reported a position in Inovio Pharmaceuticals in Q3 2014 and held it in 22 quarters.
- TCI Wealth Advisors's Inovio Pharmaceuticals position peaked at $17K in Q3 2018.
- 174 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2023.
Based on TCI Wealth Advisors's 13F filing for Q1 2023, filed 3 May 2023.